Erik Jidell

712 total citations
9 papers, 553 citations indexed

About

Erik Jidell is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Erik Jidell has authored 9 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 5 papers in Immunology and 2 papers in Genetics. Recurrent topics in Erik Jidell's work include Systemic Lupus Erythematosus Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and HER2/EGFR in Cancer Research (2 papers). Erik Jidell is often cited by papers focused on Systemic Lupus Erythematosus Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and HER2/EGFR in Cancer Research (2 papers). Erik Jidell collaborates with scholars based in Sweden. Erik Jidell's co-authors include Heidi Kokkonen, Lena Innala, Solbritt Rantapää‐Dahlqvist, Per Juto, Kenneth Persson, Anders Waldenström, Annika Allard, Stefan Söderberg, Göran Wadell and Jens Boman and has published in prestigious journals such as The Journal of Infectious Diseases, Arthritis Research & Therapy and Multiple Sclerosis Journal.

In The Last Decade

Erik Jidell

9 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erik Jidell Sweden	8	232	168	138	129	88	9	553
Bernadete L. Liphaus Brazil	14	265 1.1×	206 1.2×	58 0.4×	215 1.7×	46 0.5×	41	562
Lillemor Skattum Sweden	16	196 0.8×	136 0.8×	47 0.3×	575 4.5×	57 0.6×	40	852
Woo Dae Kang South Korea	17	50 0.2×	404 2.4×	36 0.3×	48 0.4×	78 0.9×	56	946
Rosario Nadorra United States	9	148 0.6×	24 0.1×	19 0.1×	49 0.4×	26 0.3×	10	331
Lyubica Dabich United States	15	34 0.1×	87 0.5×	34 0.2×	66 0.5×	20 0.2×	29	767
Joris Schonkeren Netherlands	10	100 0.4×	85 0.5×	24 0.2×	151 1.2×	21 0.2×	11	437
Eker Doğanavşargil Türkiye	16	202 0.9×	70 0.4×	11 0.1×	66 0.5×	13 0.1×	28	481
R. Ebringer United States	13	805 3.5×	97 0.6×	10 0.1×	351 2.7×	53 0.6×	25	1.0k
Wolfgang Meyer Germany	15	162 0.7×	265 1.6×	5 0.0×	170 1.3×	45 0.5×	52	635
V. Ognenovski United States	6	139 0.6×	64 0.4×	23 0.2×	96 0.7×	25 0.3×	10	339

Countries citing papers authored by Erik Jidell

Since Specialization

Citations

This map shows the geographic impact of Erik Jidell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Jidell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Jidell more than expected).

Fields of papers citing papers by Erik Jidell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Jidell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Jidell. The network helps show where Erik Jidell may publish in the future.

Co-authorship network of co-authors of Erik Jidell

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Jidell. A scholar is included among the top collaborators of Erik Jidell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Jidell. Erik Jidell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Innala, Lena, et al.. (2008). Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.. PubMed. 35(6). 1002–8. 84 indexed citations

Lagerqvist, Carina, Ingrid Dahlbom, Tony Hansson, et al.. (2008). Antigliadin Immunoglobulin A Best in Finding Celiac Disease in Children Younger Than 18 Months of Age. Journal of Pediatric Gastroenterology and Nutrition. 47(4). 428–435. 69 indexed citations

Sundström, Peter, L. Nyström, Erik Jidell, & Göran Hallmans. (2008). EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study. Multiple Sclerosis Journal. 14(8). 1120–1122. 41 indexed citations

Kokkonen, Heidi, et al.. (2007). The PTPN221858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Research & Therapy. 9(3). 76 indexed citations

Kokkonen, Heidi, et al.. (2007). Correction: The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden. Arthritis Research & Therapy. 9(5). 403–403. 71 indexed citations

Berglin, E, Ulf Sundin, Erik Jidell, et al.. (2004). Antibodies against cyclic citrullinated peptide before disease onset predict radiological outcome of rheumatoid arthritis. Arthritis & Rheumatism. 50. 1 indexed citations

Bengtsson, Mats, et al.. (2002). Two new HLA Cw* alleles, Cw*0105 and Cw*1405, detected by sequence based typing. Tissue Antigens. 59(3). 226–228. 8 indexed citations

Alenius, Gerd‐Marie, et al.. (2002). Disease Manifestations and HLA Antigens in Psoriatic Arthritis in Northern Sweden. Clinical Rheumatology. 21(5). 357–362. 30 indexed citations

Boman, Jens, Stefan Söderberg, Lisbeth Slunga Birgander, et al.. (1998). High Prevalence ofChlamydia pneumoniaeDNA in Peripheral Blood Mononuclear Cells in Patients with Cardiovascular Disease and in Middle‐Aged Blood Donors. The Journal of Infectious Diseases. 178(1). 274–277. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact